These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 27436451)

  • 21. Levosimendan as rescue therapy in severe cardiogenic shock after ST-elevation myocardial infarction.
    Greif M; Zwermann L; Reithmann C; Weis M
    Acute Card Care; 2008; 10(3):185-90. PubMed ID: 18972629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Successful use of levosimendan in a patient with cardiogenic shock complicating acute myocardial infarction].
    Mustapha F; Moufida H; Nedia B; Anis L; Iheb L; Habib H
    Tunis Med; 2005 Oct; 83(10):635-7. PubMed ID: 16370217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of Levosimendan on global haemodynamics in patients with cardiogenic shock.
    Rokyta R; Pechman V
    Neuro Endocrinol Lett; 2006; 27(1-2):121-7. PubMed ID: 16648778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Levosimendan is superior to enoximone in refractory cardiogenic shock complicating acute myocardial infarction.
    Fuhrmann JT; Schmeisser A; Schulze MR; Wunderlich C; Schoen SP; Rauwolf T; Weinbrenner C; Strasser RH
    Crit Care Med; 2008 Aug; 36(8):2257-66. PubMed ID: 18664782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early and sustained haemodynamic improvement with levosimendan compared to intraaortic balloon counterpulsation (IABP) in cardiogenic shock complicating acute myocardial infarction.
    Christoph A; Prondzinsky R; Russ M; Janusch M; Schlitt A; Lemm H; Reith S; Werdan K; Buerke M
    Acute Card Care; 2008; 10(1):49-57. PubMed ID: 17924229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decongestive effects of levosimendan in cardiogenic shock induced by postpartum cardiomyopathy.
    Labbene I; Arrigo M; Tavares M; Hajjej Z; Brandão JL; Tolppanen H; Feliot E; Gayat E; Ferjani M; Mebazaa A
    Anaesth Crit Care Pain Med; 2017 Feb; 36(1):39-42. PubMed ID: 27436451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inotropic agents and vasodilator strategies for acute myocardial infarction complicated by cardiogenic shock or low cardiac output syndrome.
    Unverzagt S; Wachsmuth L; Hirsch K; Thiele H; Buerke M; Haerting J; Werdan K; Prondzinsky R
    Cochrane Database Syst Rev; 2014 Jan; (1):CD009669. PubMed ID: 24385385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of Levosimendan on Patients with Heart Failure Complicating Acute Coronary Syndrome: A Meta-Analysis of Randomized Controlled Trials.
    Shang G; Yang X; Song D; Ti Y; Shang Y; Wang Z; Tang M; Zhang Y; Zhang W; Zhong M
    Am J Cardiovasc Drugs; 2017 Dec; 17(6):453-463. PubMed ID: 28597399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BET 1: Levosimendan in cardiogenic shock secondary to acute myocardial infarction.
    Emerg Med J; 2013 Dec; 30(12):1060-2. PubMed ID: 24232006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Levosimendan in patients with cardiogenic shock complicating myocardial infarction: A meta-analysis.
    Fang M; Cao H; Wang Z
    Med Intensiva (Engl Ed); 2018 Oct; 42(7):409-415. PubMed ID: 29126662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Medical Treatment of New-Onset Peripartum Cardiomyopathy: A Systematic Review of Prospective Studies.
    Desplantie O; Tremblay-Gravel M; Avram R; Marquis-Gravel G; Ducharme A; Jolicoeur EM;
    Can J Cardiol; 2015 Dec; 31(12):1421-6. PubMed ID: 26160409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [New pharmacological treatment approaches to cardiogenic shock].
    Buerke M; Russ M; Werdan K
    Internist (Berl); 2007 Dec; 48(12):1442-9. PubMed ID: 18034221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inotropic Agents and Vasopressors in the Treatment of Cardiogenic Shock.
    Shabana A; Dholoo F; Banerjee P
    Curr Heart Fail Rep; 2020 Dec; 17(6):438-448. PubMed ID: 33103204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inotrope and vasopressor use in cardiogenic shock: what, when and why?
    Hu K; Mathew R
    Curr Opin Crit Care; 2022 Aug; 28(4):419-425. PubMed ID: 35792520
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.